Kagan and Soai Win the 2026 Nobel Prize in Chemistry
Left and Right Architecture
Kenso Soai was at a neighborhood supermarket in Tokyo when his phone rang Wednesday morning. The caller was in Stockholm. Soai had just won the Nobel Prize in Chemistry. His co-laureate, Henri B. Kagan, is 95 years old and affiliated with the Université Paris-Sud in Orsay, France. French President Emmanuel Macron called the prize a recognition befitting a lifetime of research. For Kagan, that is not a figure of speech.
The Royal Swedish Academy of Sciences awarded the prize for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis. That is a technical description of something deeply strange and, once you understand it, deeply beautiful: the chemistry of choosing sides.
The Mirror Problem
Many molecules exist in two forms that are identical in every measurable way — same atoms, same bonds, same molecular weight — but are mirror images that cannot be superimposed on each other. Think of a left hand and a right hand. They carry the same components, arranged the same way. They are not interchangeable.
Chemists call this property chirality, from the Greek word for hand. The two mirror-image forms of a chiral molecule are called enantiomers. In a standard chemical reaction, both forms tend to appear in roughly equal amounts. Nature is not so indiscriminate.
Consider carvone, a common compound found in many plants. One enantiomer smells like spearmint. The other smells like caraway, the spice found in rye bread. Same molecule. Completely different sensory experience. In the context of drug design, the stakes are considerably higher. One mirror image might treat a disease. The other might do nothing — or cause harm.
Life itself resolved this problem with aggressive clarity. DNA spirals to the right. The proteins that build every organism on Earth are assembled from left-handed amino acids. The entire biochemistry of living things runs on a single chirality. How that preference ever got established — in a universe with no obvious reason to start biased in either direction — has been an open question for more than 160 years.
When the Math Stopped Being Linear
Henri Kagan's contribution came in the 1980s. Working in France, he identified what are now called non-linear effects in asymmetric synthesis. The discovery was, at first glance, simply odd.
When chemists tried to steer a reaction toward one enantiomer using a chiral catalyst, the relationship between the catalyst's purity and the product's purity was not proportional. A catalyst with only a modest chiral excess — meaning it leaned slightly toward one mirror image, but not cleanly — could produce a product with a dramatically larger chiral excess than the numbers should have permitted.
The relationship was non-linear. Something in the reaction mechanics was amplifying the initial asymmetry rather than merely reflecting it.
This had enormous implications. It meant that a small initial imbalance — a slight chemical preference for one mirror image over the other — could be amplified. You did not need a perfectly chiral starting material to end up with a highly chiral product. A nudge, under the right conditions, could become a shove.
Kagan's insight cracked the door. Kenso Soai walked through it.
The Reaction That Chooses Itself
In 1995, Soai discovered something without prior precedent in chemistry: a reaction in which the chiral product acts as a catalyst for its own continued production. He called it asymmetric autocatalysis. The world now calls it the Soai reaction.
The mechanics are striking. Start the reaction with a molecule that has only a tiny enantiomeric excess — a barely detectable lean toward one mirror image. The product of the reaction is the same molecule, and it now acts as the catalyst for the next cycle. Each cycle amplifies the initial preference. The imbalance compounds. A trace becomes a majority. A majority becomes near-total dominance.
"This is probably the coolest experiment in organic chemistry," said Peter Somfai, a member of the Nobel Committee for Chemistry.
What makes the Soai reaction genuinely arresting is the range of inputs capable of triggering it. Crystals of ordinary quartz. Circularly polarized light. Molecules that differ from each other only in which isotope of an atom occupies a particular position. The reaction is exquisitely sensitive to the faintest asymmetry in its environment — and it amplifies that asymmetry until one mirror image overwhelms the other.
The Nobel Committee described the combined work of Kagan and Soai as a feat never previously achieved by anyone other than life itself.
The Soai reaction can be triggered by a crystal of quartz or a ray of circularly polarized light. A barely detectable asymmetry becomes, through autocatalysis, near-total dominance. Chemistry, once nudged, finishes the job on its own.
Every Drug, Every Protein
The practical reach of this chemistry is not easily bounded. When asked to name the specific drugs that could not exist without asymmetric synthesis, Nobel Committee member Peter Somfai declined to offer a list. His reason was not that the list was short. His reason was that the list included essentially all of them.
Asymmetric synthesis as a field predates their work. The Nobel Committee recognized that contribution separately in 2001, awarding the chemistry prize to William Knowles, Ryoji Noyori, and Barry Sharpless for asymmetric catalysis and hydrogenation. What Kagan and Soai added was something more specific: the mechanics of amplification. Kagan showed that a catalyst with only modest chirality could produce a product with dramatically greater chirality than the inputs should have allowed. Soai showed that a reaction could drive itself toward near-total chiral dominance through autocatalysis alone. Together, those two insights changed what was possible at scale.
Modern pharmaceutical development is built on the ability to produce specific enantiomers reliably and efficiently. The wrong mirror image of a drug molecule can be inert, interfere with the intended version, or cause direct harm. Delivering a racemic mixture — equal parts of both mirror images — to patients is not acceptable pharmacology. Separating the two forms after the fact is expensive and wasteful.
What Kagan and Soai provided was the conceptual and practical foundation for making chemistry produce the correct form from the start. Rigoberto Hernandez, president of the American Chemical Society, put it plainly: the medicines available today would not exist without this chemistry. That is not marketing language. It is an accurate description of how the pharmaceutical industry operates.
The applications extend well beyond medicine. Fragrance chemistry, flavor science, and agricultural compounds all depend on chirality. Wherever a molecule's biological effect depends on which way it twists, this chemistry applies. It is not a specialized technique deployed in a narrow category of products. It is foundational infrastructure.
You did not need a perfectly chiral starting material to end up with a highly chiral product. Under the right conditions, a nudge could become a shove.
When Life Made Its Choice
The Soai reaction does something beyond solving an industrial problem. It offers a mechanistic answer to one of biology's most persistent mysteries.
If a reaction can be triggered by a quartz crystal and then amplify that trigger through autocatalysis until near-perfect chirality is achieved, then early Earth had a plausible path to homochirality. Minerals in primordial oceans. Circularly polarized light arriving from a distant source. A statistical fluctuation too small to be detected by any instrument we can build.
Any of those could have been the initial asymmetry. The Soai reaction shows how a world balanced equally between left and right could tip — and keep tipping — until one handedness so completely dominated that it became the universal template for every living thing that followed.
At a news conference at Tokyo University of Science on Wednesday, Soai said there are still fascinating aspects of the work that remain unknown. He said he hoped to continue contributing to the field, however modestly. At 76, he has time to make good on that. His co-laureate is 95 and has been at it for most of a century.
Kagan and Soai did not collaborate. Their discoveries were separated by decades and by the specific technical problems each was pursuing. But they fit together into something coherent — a picture of how chemical asymmetry gets established, amplified, and locked in. The Nobel Committee saw the connection clearly enough to award them jointly. The rest of us get to live inside the result.
Aaron Rose is a technology writer covering science and technology.